AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3369996
Drug: Capsule intact
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule intact group
Trial: 30339244
Drug: 50% reduced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50% reduced individualized GH dose (GHRID; n = 27; 20 boys)
Trial: 30339244
Drug: Unchanged individualized
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unchanged individualized GH dose (GHUID; n = 38; 27 boys)
Trial: 30339244
Drug: Standard weight-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard weight-based dose (GHFIX; n = 33; 25 boys)
Trial: 26192975
Drug: Creatine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine (1 g/d)
Trial: 22108476
Drug: Meriva (curcumin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meriva (curcumin phytosome) at a dosage of 1 g/day (two tablets/day) for four weeks
Trial: 7696451
Drug: Low viscosity
RxNorm normalized name: Gentamicin low viscosity bone cement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low viscosity budesonide enema (2 mg/100 mL)
Trial: 2821947
Drug: Higher dosages
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dosages of enalapril (40 and, if necessary 60 mg once‐a‐day)
Trial: 2821947
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg and hydrochlorothiazide 25 and, if necessary, 50 mg once‐a‐day
Trial: 26096889
Drug: Intravenous diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diclofenac sodium 37.5 mg
Trial: 26096889
Drug: Oral diclofenac
RxNorm normalized name: diclofenac Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diclofenac potassium 50 mg
Trial: 24438902
Drug: Dendritic cell
RxNorm normalized name: Dendritic cells vaccine
DrugBank: Dendritic cells vaccine (DB15803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dendritic cell immunotherapy (6 doses intravenous over 14 weeks)
Trial: 24438902
Drug: Dendritic cell
RxNorm normalized name: Dendritic cells vaccine
DrugBank: Dendritic cells vaccine (DB15803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dendritic cell immunotherapy
Trial: 18782484
Drug: Diet plus
RxNorm normalized name: Glucomannan/Grapefruit Extract/Pyridoxine Oral Tablet [GRAPEFRUIT DIET PLUS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet plus protein-calorie supplementation (formula providing 250 kcal + 20 g protein)
Trial: 12927639
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with pulsed ultrasound and interferential current (CTPI)
Trial: 28019683
Drug: Teriparatide 20
RxNorm normalized name: TERIPARATIDE 200UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide 20 μg QD
Trial: 28019683
Drug: Risedronate 35
RxNorm normalized name: risedronate 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 35 mg QW
Trial: 17168358
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (radical surgery plus pre- and intraoperative radiotherapy)
Trial: 1565181
Drug: 24,25-dihydroxycholecalciferol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24,25-dihydroxycholecalciferol (10 micrograms daily for 3 months)
Trial: 31858840
Drug: Photodynamic Therapy-ALA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic Therapy-ALA following fractional CO2 Laser
Trial: 30485924
Drug: Probiotic Lactobacillus
RxNorm normalized name: Probiotic Lactobacillus Acidophilus Caplets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic Lactobacillus casei Shirota (LcS) administered daily for 1 month
Trial: 30485924
Drug: Placebo (skimmed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (skimmed milk without probiotic) administered daily for 1 month
Trial: 26407124
Drug: pirfenidone tablets
RxNorm normalized name: Pirfenidone Tablets
DrugBank: Pirfenidone (DB04951)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: pirfenidone tablets (0.4 g) with food
Trial: 26407124
Drug: pirfenidone tablets
RxNorm normalized name: Pirfenidone Tablets
DrugBank: Pirfenidone (DB04951)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: pirfenidone tablets (0.4 g) with grapefruit juice
Trial: 17697908
Drug: Rupatadine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rupatadine 20 mg under fed conditions
Trial: 16120152
Drug: Narrowband ultraviolet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrowband ultraviolet B monotherapy
Trial: 10655708
Drug: Irradiation in
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Irradiation in breast conservation therapy (BCT)
Trial: 25452222
Drug: Guided mastery
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided mastery therapy
Trial: 25660206
Drug: Hypnotic suggestion
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic suggestion
Trial: 1676212
Drug: Topical salicylic
RxNorm normalized name: salicylic acid Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical salicylic acid
Trial: 31843964
Drug: LPS infusion
RxNorm normalized name: LP-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPS infusion
Trial: 26577263
Drug: Coronary CTA-guided
RxNorm normalized name: Glebionis coronaria whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coronary CTA-guided treatment strategy
Trial: 21163569
Drug: Intravesical BCG
RxNorm normalized name: BCG, live, Tice strain
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical BCG (27 mg)
Trial: 11339519
Drug: meloxicam 7.5
RxNorm normalized name: meloxicam 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meloxicam 7.5 mg tablet
Trial: 11339519
Drug: diclofenac 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac 100 mg slow release tablet
Trial: 9217822
Drug: 0.1% tretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% tretinoin cream applied once a day for 1 week (n=10)
Trial: 7811656
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg intranasal midazolam
Trial: 9278798
Drug: rimexolone 1%
RxNorm normalized name: RIMEXOLONE 1% SUSP,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rimexolone 1% ophthalmic suspension
Trial: 8348392
Drug: Lovastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (20 mg/day, increased to max 80 mg/day)
Trial: 8348392
Drug: Simvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (10 mg/day, increased to max 40 mg/day)
Trial: 3799503
Drug: Unsupplemented group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unsupplemented group (3-5 micrograms Se/L)
Trial: 31570084
Drug: Low-dose tirofiban
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose tirofiban treatment within the first 24 hours after IVT
Trial: 26130744
Drug: Bevacizumab plus
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab plus carboplatin (10 mg/kg every 2 weeks and carboplatin AUC 5 every 4 weeks)
Trial: 26130744
Drug: Bevacizumab monotherapy
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab monotherapy (10 mg/kg every 2 weeks)
Trial: 11472243
Drug: Antitumor prodrug
RxNorm normalized name: Troxacitabine nucleotide prodrug miv-818
DrugBank: Fostroxacitabine bralpamide (DB18090)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antitumor prodrug monotherapy targeting tumor-associated factors (hypoxia, enzymes, receptors)
Trial: 9448149
Drug: Interferon-alpha (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha (3 million U three times weekly for 6 months)
Trial: 7612090
Drug: Double phototherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double phototherapy (n = 19) with irradiance of 33 to 35 microW/cm2/nm in addition to single conventional phototherapy with combination of three or four special blue and white lamps with irradiance of 7 to 9 microW/cm2/nm
Trial: 25740691
Drug: Balugrastim 450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balugrastim 450 µg/kg
Trial: 29573207
Drug: Pegfilgrastim 6
RxNorm normalized name: PEGFILGRASTIM 6MG/0.6ML DELIVERY KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegfilgrastim 6 mg
Trial: 25740691
Drug: Balugrastim (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balugrastim (both doses)
Trial: 7537664
Drug: Casodex 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casodex 150 mg/day
Trial: 2739826
Drug: Low-dose dopamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dopamine infusion (0.1 microgram/kg/min) + hydrosaline retention
Trial: 26509152
Drug: Taper-shaped cuffs
RxNorm normalized name: caper berry extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taper-shaped cuffs
Trial: 28271073
Drug: Sorafenib (first-line
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib (first-line therapy)
Trial: 26354521
Drug: mDCF (docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mDCF (docetaxel 40 mg/m2 day 1, leucovorin 400 mg/m2 day 1, 5FU 400 mg/m2 bolus day 1, 5FU 1000 mg/m2/d days 1 and 2, cisplatin 40 mg/m2 day 3)
Trial: 26354521
Drug: EOX (epirubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EOX (epirubicin 50 mg/m2 day 1, oxaliplatin 130 mg/m2 day 1, capecitabine 1250 mg/m2/d days 1-21)
Trial: 26675778
Drug: Astaxanthin 12
RxNorm normalized name: astaxanthin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astaxanthin 12 mg/d
Trial: 11728846
Drug: Intermittent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent treatment
Trial: 2647846
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of treatment
Trial: 21808844
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg midazolam
Trial: 1980464
Drug: Lormetazepam 2
RxNorm normalized name: lormetazepam 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lormetazepam 2 mg
Trial: 2907315
Drug: Lorazepam 4
RxNorm normalized name: lorazepam 4 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 4 mg
Trial: 26454186
Drug: Interpersonal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpersonal therapy (IPT) intervention, n=104
Trial: 26454186
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU) control, n=101
Trial: 11062382
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg QD flutamide
Trial: 11062382
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg q8h flutamide
Trial: 16971821
Drug: PTSD treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTSD treatment
Trial: 21677124
Drug: HIGH (≥1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIGH (≥1200 mg calcium)
Trial: 11252549
Drug: efavirenz-containing triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: efavirenz-containing triple therapy
Trial: 11252549
Drug: indinavir-containing triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: indinavir-containing triple therapy
Trial: 9628275
Drug: Troglitazone 400
RxNorm normalized name: troglitazone 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 400 mg once daily for 8 weeks
Trial: 1957991
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with Olea europaea extracts
Trial: 21309444
Drug: Drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapy (control group)
Trial: 14816
Drug: Atenolol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (200 mg daily for five weeks)
Trial: 17260365
Drug: Reviparin 3,436
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reviparin 3,436 IU subcutaneously twice daily
Trial: 9109726
Drug: buccal bioadhesive
RxNorm normalized name: urea
DrugBank: Urea (DB03904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buccal bioadhesive slow‐release tablet containing miconazole nitrate
Trial: 31340534
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg of CurcuWIN® (50 mg of curcuminoids)
Trial: 18462734
Drug: Unidirectional buccoadhesive
RxNorm normalized name: testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unidirectional buccoadhesive bromocriptine methylate discs once daily for 1 month
Trial: 18462734
Drug: Vaginoadhesive bromocriptine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginoadhesive bromocriptine methylate discs once daily for 1 month
Trial: 15365788
Drug: l-dopa
RxNorm normalized name: L-dopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: l-dopa
Trial: 11726036
Drug: Lactoferrin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactoferrin (20 mg daily for 5 days before surgery)
Trial: 9396978
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (n = 13): encasing mattress, box springs, and pillows in allergen impermeable covers; weekly hot water wash of bed linens; replacement of bedroom carpet with polished flooring; and 3% tannic acid spray to living room carpet.
Trial: 9396978
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (n = 10): permeable encasing for bedding, cold water wash, and water spray for carpet.
Trial: 31839530
Drug: Extended-release albuterol
RxNorm normalized name: albuterol Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release albuterol
Trial: 23613501
Drug: Tidal volumes
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volumes of 6, 8, or 10 ml/kg with initial FD of sevoflurane at 2.2% vol in study 2
Trial: 15110928
Drug: High serum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High serum leptin levels at discharge from inpatient treatment
Trial: 11061603
Drug: BEACOPP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BEACOPP chemotherapy (dose-intensified variant, arm 2)
Trial: 11061603
Drug: BEACOPP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BEACOPP chemotherapy (baseline variant, arm 1)
Trial: 1390143
Drug: Pulsed electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed electromagnetic limb ulcer therapy (PELUT) device used at home for 3 hours daily for 8 weeks as an adjunct to a wound dressing
Trial: 1390143
Drug: Pulsed electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed electromagnetic limb ulcer therapy (PELUT) device
Trial: 3890197
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (recombinant DNA origin)
Trial: 3890197
Drug: Iletin II
RxNorm normalized name: NPH Iletin II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iletin II pork insulin
Trial: 24280948
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose laser (0.2 J/point)
Trial: 22496161
Drug: Sildenafil (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (100 mg/d)
Trial: 20615494
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (40 IU twice a day for 3 weeks)
Trial: 17604300
Drug: Probiotic drink
RxNorm normalized name: CVS Probiotic Drink Mix 10 Billion CFU Powder for Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic drink containing Lactobacillus casei, L bulgaricus, and Streptococcus thermophilus.
Trial: 15685041
Drug: Intracavitary hyperthermia
RxNorm normalized name: carmustine
DrugBank: Carmustine (DB00262)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracavitary hyperthermia (ICHT) combined with chemotherapy (5‐FU and mitomycin‐C) and radiotherapy.
Trial: 15685041
Drug: Chemotherapy (5‐FU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (5‐FU and mitomycin‐C) and radiotherapy without ICHT.
Trial: 9503043
Drug: Daily supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supplementation with antioxidant vitamins (vitamin C, 120 mg; vitamin E, 30 mg; beta‐carotene, 6 mg) and minerals (selenium, 100 micrograms; zinc, 20 mg)
Trial: 2691421
Drug: Analgesic nitrous
RxNorm normalized name: Nitrous Oxide
DrugBank: Nitrous oxide (DB06690)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Analgesic nitrous oxide
Trial: 24885267
Drug: Femoral nerve
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Femoral nerve block (0.5 mls/kg 0.25% levo‐bupivacaine) followed by ropivacaine (0.2% 5 ml/hr‐1) infused via a femoral nerve catheter until 48 hours post‐surgery
Trial: 9063856
Drug: Low-energy extracorporeal
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-energy extracorporeal shock wave therapy (ESWT)
Trial: 12616982
Drug: Oral 17
RxNorm normalized name: polyoxypropylene (17)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 17 beta-oestradiol daily for 6 weeks
Trial: 27352623
Drug: NIAT-rituximab (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NIAT-rituximab (375 mg/m2 intravenous rituximab on days 1 and 8)
Trial: 7742263
Drug: Felodipine ER
RxNorm normalized name: Felodipine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine ER (FER) 5 mg once daily, increased to 10 mg if necessary
Trial: 35197
Drug: Clobazam (dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobazam (dosage ranged from 5 mg daily to 120 mg daily, usual daily dosage in out-patient therapy 20-30 mg)
Trial: 35197
Drug: Clobazam (dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobazam (dosage ranged from 5 mg daily to 120 mg daily)
Trial: 28608121
Drug: Neoadjuvant S-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant S-1 with concurrent hypofractionated radiotherapy (30 Gy in 10 fractions, S-1 at 60 mg/m2, 5 days/week for 2 weeks)
Trial: 25645170
Drug: Adjunctive intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjunctive intervention consisting of two sessions of psychoeducation and skills training in reducing accommodation.
Trial: 27465573
Drug: 27‐gauge (G)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 27‐gauge (G) pars plana vitrectomy (PPV)
Trial: 27465573
Drug: 25‐G pars
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25‐G pars plana vitrectomy (PPV)
Trial: 9060195
Drug: 24-hour transdermal
RxNorm normalized name: 24 Hour Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour transdermal nicotine patch
Trial: 24341301
Drug: Vortioxetine 5
RxNorm normalized name: vortioxetine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vortioxetine 5 mg
Trial: 12811500
Drug: Oxybutynin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin (5 mg twice daily)
Trial: 8683844
Drug: GnRH‐agonist therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH‐agonist therapy after drainage of endometrioma for 6 months
Trial: 8683844
Drug: GnRH‐agonist therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH‐agonist therapy alone for 6 months
Trial: 27265353
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral co-trimoxazole prophylaxis (120 mg/day for <6 months, 240 mg/day for 6 months to 5 years)
Trial: 27265353
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral co-trimoxazole prophylaxis
Trial: 22285724
Drug: Atomoxetine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (mean final dose = 1.38 mg/kg)
Trial: 16998214
Drug: Statin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin treatment (mainly atorvastatin) in Group A
Trial: 16998214
Drug: No statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No statin treatment in Group B
Trial: 16998214
Drug: Statin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin treatment in Group C (without MetS)
Trial: 16998214
Drug: No statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No statin treatment in Group D (without MetS)
Trial: 15237767
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (800 mg/d)
Trial: 2717287
Drug: Nonnutritive sucking
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonnutritive sucking (pacifier for 30 minutes with each feeding, 12 times per day until weight of 1,500 g, then 8 times per day)
Trial: 1098832
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg of folic acid after dialysis
Trial: 1098832
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of folic acid after dialysis